Bio-Techne Corp (TECH)

382.97 0.40%
02:40 pm EDT; Powered by IEX
Pros
Revenue growth higher than the industry and sector averages
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Buy analyst rating
Average analyst stock price above current stock price
Cons
Forward P/B ratio high relative to industry peers
Forward PEG ratio high relative to industry peers
High short interest

Pros

  1. TECH quarterly revenue growth was 20.10%, higher than the industry and sector average revenue growth (4.07% and 7.51%, respectively). See TECH revenue growth chart.
  2. TECH profitability is improving. The YoY profit margin change was 6.09 percentage points. See TECH profitability chart.
  3. TECH forward dividend yield is 0.35%, higher than the industry (0.02%) and sector (0.20%) forward dividend yields. See TECH forward dividend chart.
  4. TECH average analyst rating is Buy. See TECH analyst rating chart.
  5. TECH average analyst price target ($500.54) is above its current price ($383.26). See TECH price target chart.

Cons

  1. TECH Price/Book ratio is 9.23, which is high compared to its industry peers’ P/B ratios. See TECH forward Price/Book ratio chart.
  2. TECH PEG ratio (P/E adjusted for growth) is 2.85, which is high compared to its industry peers’ PEG ratios. See TECH PEG chart.
  3. TECH short interest (days to cover the shorts) ratio is 2.5. The stock garners more short interest than the average industry, sector or S&P 500 stock. See TECH short interest ratio chart.